Galantamine tethered hydrogel as a novel therapeutic target for streptozotocin-induced Alzheimer's disease in Wistar rats
Amyloid-β (Aβ) plaque formation, neuronal cell death, and cognitive impairment are the unique symptoms of Alzheimer's disease (AD). No single step remedy is available to treat AD, so the present study aimed to improve the drugability and minimize the abnormal behavioral and biochemical activiti...
Saved in:
Main Authors: | Manickam Rajkumar (Author), Murugesan Sakthivel (Author), Kottaisamy Senthilkumar (Author), Ramasundaram Thangaraj (Author), Soundarapandian Kannan (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanistic insights into MARK4 inhibition by galantamine toward therapeutic targeting of Alzheimer's disease
by: Mohd Adnan, et al.
Published: (2023) -
Comparative study of rivastigmine and galantamine on the transgenic Drosophila model of Alzheimer's disease
by: Yasir Hasan Siddique, et al.
Published: (2022) -
Protective Effect of Acacia nilotica (L.) against Acetaminophen-Induced Hepatocellular Damage in Wistar Rats
by: Narayanan Kannan, et al.
Published: (2013) -
Chitosan-Based Nanoparticles for Targeted Nasal Galantamine Delivery as a Promising Tool in Alzheimer's Disease Therapy
by: Dilyana Georgieva, et al.
Published: (2023) -
Galantamine ameliorates experimental pancreatitis
by: Dane A. Thompson, et al.
Published: (2023)